Guardian Capital LP on March 4 debuted its Guardian i 3 Global Dividend Premium Yield Fund and ETF (TSX: GIDY). The invests primarily in global dividend-paying securities and uses a dynamic ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

We also observed large increases in downstream anti-cancer immune cytokines, including interferon-gamma, our FDA-endorsed potency assay and TGF-alpha ... with extensive global clinical development ...

Obsidian Therapeutics, a specialist in tumour-infiltrating lymphocyte (TIL) cell therapies, has raised $160.5 million in a third-round financing round that will be used to fund its clinical ...

During this time of uncertainty about the future role of the world’s biggest donor, the Global Fund stands as a beacon of hope. Since the beginning of the millennium, the Geneva-based multilateral ...

Asset managers rely on fund flow data to interpret investor behavior on a macro level. Download this edition of Morningstar’s annual Global Fund Flows report. Find out which of the largest fund ...

To address the shortfall, Just Climate has raised $175 million from Microsoft’s Climate Innovation Fund and CalSTRS.

On the lookout for a Global - Equity fund? Starting with T. Rowe Price Global Stock (PRGSX) should not be a possibility at this time. PRGSX bears a Zacks Mutual Fund Rank of 5 (Strong Sell), which is ...

Contributions to the Cali Fund will be allocated to the implementation of the Convention on Biological Diversity, including by supporting the implementation of the Kunming- Montreal Global ...